India vs Sur: Number of new G2D leprosy cases
India
1,888
in 2024
Sur
1
in 2024
India rank
2nd
Sur rank
1st
Number of new G2D leprosy cases over time
- India
- Sur
How they compare
India currently reports 1,888 against 1 in Sur, a difference of 1,887.
That makes India's figure about 1,888.0 times Sur's.
Across all 13 years both countries report, India has been ahead every year.
India ranks 2nd and Sur ranks 1st of 161 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4,722 | 1.5 | 4,720 | India |
| 2020s | 2,004 | 1.4 | 2,003 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of new g2d leprosy cases, India or Sur?
- India, at 1,888 against 1 in Sur as of 2024.
- What is the difference in number of new g2d leprosy cases between India and Sur?
- 1,887, with India ahead.
- How many years of comparable data are there for India and Sur?
- 13 years are reported by both, from 2012 to 2024.
- How do India and Sur rank globally for number of new g2d leprosy cases?
- India ranks 2nd and Sur ranks 1st of 161 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of new G2D leprosy cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.